Clinical Trials
2 trialsNCT04099641 2023-02-08
An Open Label Study of Bavituximab and Pembrolizumab in Advanced Gastric and GEJ Cancer Patients
OncXerna Theraputics, Inc.
Phase 2 Completed
NCT01272791 2017-04-19
Trial of Gemcitabine With or Without Bavituximab in Patients With Previously Untreated Stage IV Pancreatic Cancer
Peregrine Pharmaceuticals
Phase 2 Completed